A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data

C. Leissinger, C. Negrier, Erik Berntorp, J. Windyga, M. Serban, A. Bulent, R. Lassila, K. Kavakli, B. Zulfikar, A. Gringeri

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)31-31
JournalHaemophilia
Volume16
Issue numberSuppl. 4
DOIs
Publication statusPublished - 2010
EventXXIXth International Congress of the World Federation of Hemophilia - Buenos Aires, Argentina
Duration: 2010 Jul 102010 Jul 14

Subject classification (UKÄ)

  • Hematology

Cite this